KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Brock L, Benzien L, Lange S, Huehns M, Runge A, Roolf C, Sekora A, Knuebel G, Murua Escobar H, Junghanss C, Richter A.
Brock L, et al. Among authors: lange s.
Mol Oncol. 2025 Jan 4. doi: 10.1002/1878-0261.13792. Online ahead of print.
Mol Oncol. 2025.
PMID: 39754404
Free article.